Health Canada Approves Nintedanib to Treat Rare Lung Disease
Health Canada has approved Ofev (nintedanib) to treat patients with systemic sclerosis associated interstitial lung disease (SSc-ILD).
Meeting Coverage
Your next patient meeting or conference is a great opportunity to interview physicians, researchers, patients, and caregivers while everybody is in one place.
More...
More...
Website Content
We can provide original, tailor-made content for your website on a regular basis to improve the site’s google ranking and audience size.
More...
More...
Website Development
The Zeal Access team has years of experience in web design and patient advocacy. We understand what an advocacy group’s website should look like and what it should contain.
More...
More...
